Impact of tafamidis on myocardial function and CMR tissue characteristics in transthyretin amyloid cardiomyopathy

Abstract Aims Tafamidis improves clinical outcomes in transthyretin amyloid cardiomyopathy (ATTR‐CM), yet how tafamidis affects cardiac structure and function remains poorly described. This study prospectively analysed the effect of tafamidis on 12‐month longitudinal changes in cardiac structure and...

全面介紹

書目詳細資料

Principais autores:	Stephan Dobner, Benedikt Bernhard, Lorenz Ninck, Monika Wieser, Adam Bakula, Andreas Wahl, Valentin Köchli, Giancarlo Spano, Martina Boscolo Berto, Elena Elchinova, Yasaman Safarkhanlo, Stefan Stortecky, Jonathan Schütze, Isaac Shiri, Lukas Hunziker, Christoph Gräni
格式:	Artigo
語言:	Inglês
出版:	Oxford University Press 2024-10-01
叢編:	ESC Heart Failure
主題:	Cardiac amyloidosis Cardiac magnetic resonance imaging ECV Feature tracking GLS Tafamidis
在線閱讀:	https://doi.org/10.1002/ehf2.14815
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!